Influenza D virus (IDV) was first reported in 2011 in swine in Oklahoma and consequently found in cattle, sheep, and goats across North America and Eurasia. Cattle have been proposed as the natural reservoir. In this study, we developed and validated a MAb-based competitive ELISA for the detection of antibodies against IDV.
surface glycoproteins, haemagglutinin (HA), and neuraminidase (NA). Influenza C virus (ICV) and Influenza D virus (IDV) have only seven segments with only one surface glycoprotein, the haemagglutinin-esterase-fusion, or HEF protein that shows receptor binding, receptor destroying, and membrane fusion activities, thus combining the functions of HA and NA of IAV and IBV (Kapoor & Dhama, 2014) . IDV was first identified in 2011 in the United
States from a pig with influenza-like symptoms and has subsequently been found in both healthy and sick cattle from multiple geographic areas across the United States, China, France, Italy, Japan, and Ireland (Hause et al., 2013; Jiang et al., 2014; Ducatez, Pelletier, & Meyer, 2015; Chiapponi et al., 2016; Murakami et al., 2016; Flynn et al., 2018) . Moreover, serological analysis proved evidence of IDV circulation among small ruminants in the United States with 13.5% and 13.3% of prevalence in sheep and goat farms respectively, but not among turkeys and chickens (Quast et al., 2015) . Another study reported a seroprevalence of 91% among individuals working with cattle in Florida (White, Ma, McDaniel, Gray, & Lednicky, 2016) .
Among these hosts, cattle have been proposed as the reservoirs for IDV, even if the pathogenesis of IDV in cattle is still unresolved. The newly emerged virus was prevalent in samples originated from bovines with respiratory diseases belonging to the bovine respiratory disease complex (BRDC). The BRDC etiological agents included BVD, BHV1, BRSV, and PI3 and recently IDV has also been proposed as an agent causing BRDC (Ferguson et al., 2016) .
Since the discovery of IDV, pigs (Foni et al., 2017; Hause et al., 2013) , cows (Ducatez et al., 2015; Chiapponi et al., 2016; , ferrets, guinea pigs , sheep, goats (Quast et al., 2015) , dromedary camels (Salem et al., 2017) , and horses (Nedland et al., 2018) have been found susceptible to the virus.
Because ferrets and guinea pigs are both considered models for human influenza virus studies and multiple animal species as well as humans are susceptible to influenza virus suggests that IDV may have a wider host range than currently expected. Other potential hosts of IDV consequently need to be determined and the serological studies could be a valuable tool.
Two of the most common methods for measuring serum antibody to influenza are the haemagglutination inhibition (HI) and virus neutralisation (VNT) assays. Although they are valuable serologic methods, a common problem observed by both methods is the poor reproducibility among laboratories. Other disadvantages of VNT are difficulty level, time required to perform the test, and the need for live virus. Also, HI has some disadvantages such as subjectivity of results interpretation and reliability issues in relation to freshness of reagents, in addition to being a time-consuming and labour-intensive method. The HI test may also be complicated by the presence of non-specific inhibitors of viral haemagglutination and naturally occurring agglutinins of the erythrocytes. Therefore, false-positive or -negative results may arise if the sera are not treated before use (Truelove et al., 2016) .
Enzyme-linked immunosorbent assay (ELISA) is another option widely used for serological diagnosis of influenza virus. ELISA methods are subdivided based on their approach, and include both indirect and competitive methods. The main benefit of the competitive ELISAs over indirect ELISAs is that the competitive ones do not require the use of species-specific enzyme-conjugated antibodies as do the indirect ELISAs. For this reason, competitive ELISA tests for antibody detection enable testing of samples of different animal species. In the current study, a monoclonal antibody (MAb)-based competitive ELISA assay for the detection of anti-IDV antibodies in sera of different animal species was developed and validated. The principle of this ELISA relies on the use of MAbs specific for IDV, so that only serum antibodies homologous to the virus belonging to type D, which is recognized by the selected competitor MAb, will specifically block the virus-MAb reaction.
| MATERIALS AND METHODS

| Viruses
The IDV isolate D/Swine/Italy/199724-3/2015 was used as an immunogen for MAb production. The same IDV strain was also used as the source of antigen for the reported competitive ELISA. It was isolated on HRT18 cell cultures and cell culture supernatant was evaluated for haemagglutination activity and tested by real-time polymerase chain reaction (PCR) as previously described . For antigen production, the supernatant of HRT18 infected cells was clarified, inactivated with ß-propiolactone, and then partially purified by 25% (w/w) sucrose cushion ultracentrifugation for 2 hr at 74,500 g. belonging to D/660 lineages 
| MAb production and characterisation
One Balb/c mouse was primed subcutaneously with partially purified virus in Freund complete adjuvant and boosted intraperitoneally with the same antigen in phosphate buffered saline (PBS) 1 month later.
The mouse was euthanised 3 days after the booster injection and hybridomas were generated following fusion of splenocytes with NSO myeloma cells; cultures of the selected fusion products were grown according to standard procedures (Harlow & Lane, 1988) 
| ELISA for MAb characterisation
MAbs were characterized through indirect, competitive, and IDV sandwich ELISAs performed as described previously (Moreno et al., 2009 ). For the indirect ELISAs, partially purified IDV and heterologous influenza viruses were adsorbed onto Nunc Maxisorp microplates by overnight incubation at 4°C; the plates were then sequentially incubated with hybridoma supernatants and HRPO-conjugated goat anti-mouse immunoglobulin antibodies (produced inhouse using the method described by Tjissen (Tjissen & Kurstak, 1984) for 1 hr at 37°C. The dilution buffer consisted of PBS (pH 7.4) with 0.05% Tween 20 and 1% yeast extract. The substrate solution (0.5 mg/ml orthophenylenediamine and 0.02% H 2 O 2 in 50 mM phosphate-citrate buffer [pH5]) was then added. After 10 min, the colorimetric reaction was stopped by the addition of 2N sulphuric acid; absorbance values were read at 492 nm using a plate reader. For the competitive binding assays, competitive ELISAs were designed to analyse the capability of known experimental sera to inhibit the binding of anti-IDV MAbs to their homologous IDV. Fifty microlitres of serially diluted known sera were incubated for 1 hr at 37°C in IDV-coated immunoplates and after washing, 25 μl of hybridoma supernatant was added. The hybridoma supernatant was previously diluted to give an absorbance value of 1-1.5 in the preliminary titration. Binding of the MAb was detected with HRPO-conjugated anti-mouse immunoglobulins (produced in-house) and the colorimetric reaction was performed as previously described. 
| HI assay
The HI assay was performed to evaluate the ability of selected MAbs to inhibit haemagglutination by the homologous IDV. In addition, it was used to validate the results of IDV-cELISA by testing all sera in parallel. The HI assay was performed as described previously (OIE manual) using 1% chicken red blood cells and 8 hemagglutinin units from D/Swine/Italy/199724-3/2015. An HI titre >1/20 was considered positive. A preliminary serum pre-treatment to remove nonspecific inhibitors was performed. Fifty microlitres of serum was added to 200 μl receptor destroying enzyme (1/10 dilution in calcium saline solution equalling 100 units per ml). After incubation overnight (12-18 hr) in a 37°C water bath, 150 μl of 2.5% sodium citrate solution was added. Samples were further heat inactivated at 56°C for 30 min.
| Virus neutralisation test
In order to detect neutralizing monoclonal antibodies, the MAbs that were positive by competitive and indirect ELISAs and HI assay were tested by VNT as described previously (Moreno et al., 2009 Moreover, a panel of 118 sera (51 HI-positive and 67 HI-negative sera) was also tested by VNT using two-fold serial dilutions starting from one-half. Detection of neutralizing antibodies was deduced by presence or absence of viral infection using the anti-IDV MAb 2E12 conjugated to HRP.
| Panel of sera used for test evaluation
A panel of 914 sera obtained from humans and different animal species was used comprising 444 negative and 470 positive sera for IDV. Samples were tested by HI test and were divided into the categories detailed in Table 1 . 
| Statistical analysis
The agreement between IDV-cELISA and homologous HI test was assessed by Cohen's κ value. The κ values were interpreted according to the Landis and Koch descriptors (Landis & Koch, 1977) A ROC curve is a graphical representation of the relative effects of the false-negative and false-positive rates for every possible cut-off and is a valid tool to evaluate the discriminatory power of a diagnostic test. The area under the curve (AUC) is a global statistic summary of diagnostic accuracy and can distinguish between noninformative (AUC = 0.5), less accurate (0.5 < AUC ≤ 0.7), moderately accurate (0.7 < AUC ≤ 0.9), highly accurate (0.9 < AUC < 1), and perfect tests (AUC = 1) (Swets, 1988) . 
| Setup and standardisation of competitive
ELISA for detection of anti-IDV antibodies
In order to standardize the test, the parameters that could influence In the first configuration, the competitive binding between serum and MAb was assessed using the 3G3 MAb coated to the plate to capture the IDV-infected cell culture supernatant; in the second, the competitive binding was assayed with a partially purified IDV antigen directly adsorbed to the plate microwells. Furthermore, the sequential or simultaneous incubation of serum antibodies and conjugated MAb was evaluated. A solid-phase ELISA with partially purified IDV adsorbed to the plate; the incubation of serum alone followed by washing and addition of the conjugated 2E12 MAb showed the best combination of assay performance and speed, and was then selected for further validation. Finally, in order to select an optimal dilution for test sera, serial dilutions of the five sera, ranging from 1/2 to 1/ 512, were tested with the selected competitive ELISA (Figure 1) .
A clear-cut separation between homologous and heterologous positive sera was recorded, suggestive of a satisfactory analytical specificity. The dilutions 1/10 and 1/20 provided a wide window between positive and negative samples.
| Diagnostic performances
The agreement between IDV-cELISA and HI test was assessed by 
| DISCUSSION
Since IDV was discovered, several animal species have been found susceptible to the virus, drawing attention to the fact that IDV could have a wider host range than currently expected (Quast et al., 2015; Salem et al., 2017) . Serological studies are valuable tools to better investigate the prevalence and diffusion of IDV in different hosts and thus, the aim of this study was to develop a simple and reliable method to detect antibodies against IDV in different animal species. The IDV-cELISA here described is a MAb Other field positive and negative sera were randomly selected from different animal species and were tested in parallel by IDVcELISA and HI test. In order to better evaluate the specificity of the IDV cELISA, sera originating from humans, chickens, and pigs strongly positive to other influenza viruses were included in the negative population without any observed cross-reactions.
A very good agreement was observed between the HI test and the new IDV-cELISA; however, it should be noted that despite the excellent agreement between both tests, some outliers were observed. Twelve samples originated from bovine farms tested positive for IDV PCR, resulted positive in the IDV-cELISA but did not contain measurable HI antibodies. Considering that 8 out of 12 samples were also positive by VNT, we supposed that the lack of correspondence between these methods could be due to a higher sensitivity showed by ELISAs methods versus VNT as well as VNT versus HI test (Grund, Adams, Wählisch, & Schweiger, 2011) .
Moreover, phylogenetic and antigenic studies of IDV viruses Odagiri et al., 2018) Nedland et al., 2018) . The D/OK lineage has been found in Europe and China (Foni et al., 2017; Jiang et al., 2014) , whereas the D/Japan lineage circulate only in Japan (Odagiri et al., 2018) . Although the three IDV lineages show different antigenic properties, serologic cross-reactivity between the IDV lineage-representatives viruses was demonstrated by the HI test (Nedland et al., 2018; Odagiri et al., 2018) .
Considering this, we could suppose that this cross-reactivity would be higher when ELISA tests able to detect type-specific antibodies were used. The IDV-cELISA here described is based on a whole virus Furthermore, a series of properties of this competitive ELISA, such as the feasibility of testing sera without pre-treatment, automation, and instrumental reading, make the new ELISA ideal for screening and confirming HI-positive results or in the case of samples that are difficult to interpret in HI assays.
